In a statement drugmaker AstraZeneca said, a three-dose course of COVID-19 vaccine is effective against the Omicron variant of the coronavirus, citing data from an Oxford University lab study. The results of the study, which is yet to be published… Read More ›
In a statement Moderna Inc said, a booster dose of its COVID-19 vaccine appears to protect against the fast-spreading Omicron variant of COVID-19 in laboratory tests; its current version of the vaccine will continue to be its “first line of defense… Read More ›
manageria.biz 